Literature DB >> 9292062

Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion.

I C Le Poole1, R M van den Wijngaard, W Westerhof, P K Das.   

Abstract

The aetiology of vitiligo remains obscure. In this study, the role of integrins in the observed inability of melanocytes to repopulate lesional skin was investigated. Antibodies directed to alpha 2, alpha 3, alpha 5, alpha v, alpha 6, beta 1 and beta 3 integrin subunits were used. Immunohistology revealed no marked differences in the overall levels of expression of integrins between control, non-lesional perilesional or lesional skin. Moreover, no differences were noted in the level of expression of integrins or the adhesive capacity between cultured control cells derived from three separate donors and vitiligo-derived melanocytes from two donors. Rather, it was clearly observed that towards the lesion, vitiligo skin contains increasing amounts of tenascin in the basal membrane and papillary dermis in five patients employing T2H5 antihuman tenascin antibody. The anti-adhesive effect observed in vitro for this extracellular matrix molecule using normal melanocytes may contribute to loss of pigment cells in vitiligo or to ineffective repopulation of the lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292062     DOI: 10.1046/j.1365-2133.1997.18011894.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

Review 1.  Highlights in pathogenesis of vitiligo.

Authors:  Ghada F Mohammed; Amal Ha Gomaa; Mohammed Saleh Al-Dhubaibi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

2.  Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.

Authors:  Nesrine Boukhedouni; Christina Martins; Anne-Sophie Darrigade; Claire Drullion; Jérôme Rambert; Christine Barrault; Julien Garnier; Clément Jacquemin; Denis Thiolat; Fabienne Lucchese; Franck Morel; Khaled Ezzedine; Alain Taieb; François-Xavier Bernard; Julien Seneschal; Katia Boniface
Journal:  JCI Insight       Date:  2020-06-04

Review 3.  Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.

Authors:  Stanca A Birlea; Gertrude-E Costin; Dennis R Roop; David A Norris
Journal:  Med Res Rev       Date:  2016-12-28       Impact factor: 12.944

4.  CTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population.

Authors:  Farha Deeba; Rabbani Syed; Jariya Quareen; M A Waheed; Kaiser Jamil; Hanmanth Rao
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

Review 5.  Vitiligo--part 1.

Authors:  Roberto Gomes Tarlé; Liliane Machado do Nascimento; Marcelo Távora Mira; Caio Cesar Silva de Castro
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

6.  Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo.

Authors:  M Emin Yanik; Gamze Erfan; Yakup Albayrak; Murat Aydin; Mustafa Kulac; Murat Kuloglu
Journal:  Neuropsychiatr Dis Treat       Date:  2014-12-12       Impact factor: 2.570

Review 7.  Skin Pigmentation and Pigmentary Disorders: Focus on Epidermal/Dermal Cross-Talk.

Authors:  Emanuela Bastonini; Daniela Kovacs; Mauro Picardo
Journal:  Ann Dermatol       Date:  2016-05-25       Impact factor: 1.444

Review 8.  Clinical and Molecular Aspects of Vitiligo Treatments.

Authors:  Anuradha Bishnoi; Davinder Parsad
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

Review 9.  Novel immunological and genetic factors associated with vitiligo: A review.

Authors:  Salvador Luis Said-Fernandez; Celia Nohemi Sanchez-Domínguez; Mauricio Andres Salinas-Santander; Herminia Guadalupe Martinez-Rodriguez; David Emmanuel Kubelis-Lopez; Natalia Aranza Zapata-Salazar; Osvaldo Tomas Vazquez-Martinez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-02-01       Impact factor: 2.447

Review 10.  Concise review of recent studies in vitiligo.

Authors:  Mohamed Allam; Hassan Riad
Journal:  Qatar Med J       Date:  2013-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.